A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
Clinical trial NCT03519945 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03519945
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-18
- Primary completion
- 2026-03-04
- Enrollment
- 1058
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.